Gina Bartasi
About Gina Bartasi
Gina Bartasi is the Founder and Executive Chairman of Kindbody, a family-building benefits provider. With over 20 years of experience in health tech, she has previously held leadership roles at FertilityAuthority.com and Progyny, and has a strong background in strategic mergers and business growth.
Current Role at Kindbody
Gina Bartasi serves as the Founder and Executive Chairman of Kindbody, a family-building benefits provider. She has held this position since 2022. In addition to her role as Executive Chairman, she also functions as the Chief Executive Officer, a position she has maintained since 2018. Under her leadership, Kindbody has established partnerships with over 100 blue-chip employers, providing coverage for more than 2.4 million lives. The company has successfully raised $230 million in debt and equity funding to support its growth and expansion.
Previous Experience at FertilityAuthority.com
Prior to her current roles, Gina Bartasi was the Founder, Chief Executive Officer, and Board Director of FertilityAuthority.com from 2008 to 2017. During her nine years in this position, she contributed to the growth and development of the platform, which focused on fertility resources and services. This experience laid the groundwork for her subsequent ventures in the health tech sector.
Educational Background
Gina Bartasi studied at the University of North Carolina at Chapel Hill from 1987 to 1991, where she completed her undergraduate education. She furthered her education at Harvard Business School, where she participated in the Owner/President Management Program from 2002 to 2004 and later completed the Private Equity Venture Capital program in 2017. This academic background has equipped her with the skills necessary for her leadership roles in the health tech industry.
Entrepreneurial Ventures and Achievements
Gina Bartasi has a proven track record in the health tech industry, with over 20 years of experience. She founded Progyny in 2015, where she scaled its fertility benefits offerings and secured partnerships with major tech employers. Additionally, she led a strategic merger forming Progyny after being recruited by life sciences investors at Kleiner Perkins and TPG. Bartasi also played a key role in the turnaround of Auxogyn’s Eeva, a medical device investment, which was sold to Merck for $8 million.
Leadership in Tech-Health
In addition to her roles at Kindbody and Progyny, Gina Bartasi is the Founder and Chief Executive Officer of Tech-Health, a position she has held since 2017. Her leadership in this venture reflects her commitment to advancing health technology and improving access to healthcare solutions.